Seaport Therapeutics, Inc. SPTX
$18.02
▲ +1.58% 24H
About
Seaport Therapeutics, Inc. is a clinical-stage biotechnology company focused on inventing and developing novel oral medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company employs its proprietary Glyph platform to address limitations of clinically validated mechan…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees58
TickerSPTX
Statistics
Market Cap$955.3M
Revenue (TTM)$0
Net Income-$74.9M
Net Margin—
EPS$-1.94
P/E-9.15
P/S—
P/B-8.15
EV/EBITDA-10.57
ROE-28.1%
Dividend Yield—
Price$18.02
Data: Twelve Data · Revenue = mcap / P/S